IDEXX Laboratories Inc
IDEXX Laboratories (IDXX) is showing impressive financial strength with a current price of $591.84, reflecting a 2.96% increase today. The company has a robust EPS growth of 22.64% year-over-year and a remarkable return on equity (ROE) of 69.78%, indicating effective management and high profitability. With a market cap of $47.12B and a current price well below its 52-week high of $769.98, IDXX presents an attractive investment opportunity.
Buy IDXX shares, as its strong financial performance and market position suggest significant upside potential.
IDEXX Laboratories to Release 2026 First Quarter Financial Results
2026-04-08
Will UK Rollout of Early Canine Cancer Test Change IDEXX Laboratories' Preventive Care Narrative?
2026-04-08